| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | LUNG Pulmonx Corp | Joshi Mehul73 | Chief Financial Officer &Pao | Sell | 14,384 | $7.12 | $102,414.08 | -11.2% | -62.2% | -81.6% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.62 | Chief Financial Officer | Sell | 2,341 | $108.77 | $254,630.57 | -4.9% | +28.9% | +15.4% | |
| Mar 3, 2025 | NXGL Nexgel, Inc. | Levy Adam R.77 | Chief Executive Officer | Sell | 4,000 | $3.16 | $12,638.80 | -1.1% | -23.2% | -61.9% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | Sell | 314 | $108.77 | $34,153.78 | -2.7% | +28.9% | +15.4% | |
| Mar 3, 2025 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 535 | $10.28 | $5,499.32 | -1.0% | -19.3% | -79.4% | |
| Mar 3, 2025 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 2,973 | $1.41 | $4,183.01 | -1.6% | -24.9% | +16.0% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Shrishrimal Sumi60 | EVP, Chief Risk Officer | Sell | 1,726 | $108.77 | $187,737.02 | -4.6% | +28.9% | +15.4% | |
| Mar 3, 2025 | PEN Penumbra Inc | Bose Arani57 | Director | Sell | 12,000 | $287.42 | $3,448,992.77 | -0.3% | -10.4% | +19.0% | |
| Mar 3, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 660 | $25.46 | $16,803.60 | -0.5% | -15.6% | -17.7% | |
| Mar 3, 2025 | PEN Penumbra Inc | Yuen Maggie49 | Chief Financial Officer | Sell | 2,000 | $286.00 | $571,994.90 | -2.4% | -10.4% | +19.0% | |
| Mar 3, 2025 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 5,779 | $7.13 | $41,193.02 | -0.5% | -62.2% | -81.6% | |
| Mar 3, 2025 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 276 | $10.25 | $2,829.69 | -0.7% | -19.3% | -79.4% | |
| Mar 3, 2025 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 424 | $25.46 | $10,795.04 | -0.4% | -15.6% | -17.7% | |
| Mar 3, 2025 | XRAY Dentsply Sirona Inc. | Lucier Gregory T45 | Director | Buy | 15,142 | $16.51 | $249,994.42 | +22.7% | -2.3% | -16.8% | |
| Mar 3, 2025 | PACB Pacific Biosciences Of California, Inc. | Van Oene Mark79 | See Remarks | Sell | 6,486 | $1.41 | $9,125.80 | -0.4% | -24.9% | +16.0% | |
| Mar 3, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 284 | $25.46 | $7,230.64 | -0.5% | -15.6% | -17.7% | |
| Mar 3, 2025 | NVCR Novocure Ltd | Leonard Frank X76 | EVP, Pres., Novocure Oncology | Sell | 2,527 | $18.54 | $46,841.23 | -1.7% | -7.4% | -27.8% | |
| Mar 3, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 324 | $25.46 | $8,249.04 | -0.2% | -15.6% | -17.7% | |
| Mar 3, 2025 | ABT Abbott Laboratories | Shroff Eric | Senior Vice President | Sell | 562 | $138.17 | $77,651.54 | -1.7% | -4.7% | -19.0% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Turakhia Minang46 | EVP, CMO &CSO | Sell | 2,467 | $108.77 | $268,335.59 | -5.5% | +28.9% | +15.4% | |
| Mar 3, 2025 | NVCR Novocure Ltd | Cordova Ashley75 | Chief Executive Officer | Sell | 2,053 | $18.54 | $38,055.02 | -1.0% | -7.4% | -27.8% | |
| Mar 3, 2025 | ABT Abbott Laboratories | Moreland Mary K56 | Executive Vice President | Sell | 791 | $138.17 | $109,292.47 | -0.8% | -4.7% | -19.0% | |
| Mar 3, 2025 | ABT Abbott Laboratories | Morrone Louis H.70 | Executive Vice President | Sell | 1,111 | $138.17 | $153,506.87 | -1.6% | -4.7% | -19.0% | |
| Mar 3, 2025 | INGN Inogen Inc | Bourque Michael J. | EVP, CFO &Treasurer | Buy | 3,000 | $8.32 | $24,960.00 | +6.7% | -21.8% | -23.6% | |
| Mar 3, 2025 | ABT Abbott Laboratories | Wainer Andrea F70 | Retired EVP | Sell | 949 | $138.17 | $131,123.33 | -1.3% | -4.7% | -19.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.